Inotuzumab ozogamicin Intravenous and Pancuronium Bromide
Determining the interaction of Inotuzumab ozogamicin Intravenous and Pancuronium Bromide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
Generic Name: pancuronium
Brand name:
Synonyms: Pancuronium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin Intravenous-Pandel
- Inotuzumab ozogamicin Intravenous-Pandel Topical application
- Inotuzumab ozogamicin Intravenous-Pangestyme EC
- Inotuzumab ozogamicin Intravenous-Panhematin
- Inotuzumab ozogamicin Intravenous-Panitumumab
- Inotuzumab ozogamicin Intravenous-Panitumumab Intravenous
- Pancuronium Bromide-Inova
- Pancuronium Bromide-Inova 4/1 topical
- Pancuronium Bromide-Inova 8/2 topical
- Pancuronium Bromide-Inova ACT
- Pancuronium Bromide-Inrebic
- Pancuronium Bromide-Inspra